Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer

ABSTRACT: The purpose of this trial is to determine the safety and efficacy of Zalutumumab alone or in combination with Irinotecan for the treatment of patients with Colorectal Cancer

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2055391 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR